Cytology and HPV Testing World Markets

Questions: Discounts, Updates etc.

Pages: 177

Price: $3400

Publication Date: 2008-07-02

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

The purpose of this report is to describe the specific segment of the diagnostics market aimed at the cytological analysis of specimens derived from the human female reproductive tract. It examines the measurement devices and their reagents and supplies used in hospitals, clinics, commercial laboratories and research institutions to detect cells and proteins for the diagnosis and monitoring of disease.

The study describes the analytical methods used to separate, isolate, characterize and quantitate cells, DNA and proteins complex in biological systems related to the diagnosis and treatment of disease of the female reproductive tract, such as the cervix and vagina.

The emphasis is on those companies and products that are actively developing and marketing laboratory instrumentation, reagents and supplies for performing cytology and related molecular diagnostic tests, such as human papillomavirus (HPV), cervical cancer and other inflammatory and sexually-transmitted diseases.

Table of Contents

 

  • Appendix 1: Breast Cancer173

  • Appendix 2: Ovarian Cancer175

  • Appendix 3: Malignant Melanoma176


  • INDEX OF TABLES

  • Table 2.1: Drug Development by Type of Cancer11
  • Table 2.2: The 402 Organ Specific Medicines in Development for Cancer12
  • Table 2.3: Leading Sites of Cancer Cases and Deaths in the U.S. by Sex13
  • Table 2.4: Estimated New Cancer Cases and Deaths by Type of Cancer, 200814
  • Table 2.5: Estimated Number of New Cancer Cases and Deaths by World Area 200715
  • Table 2.6: Cancer Death Rates per 100,000 Population (and Rank) for All Cancer Sites by Country16
  • Table 2.7: Cancer-Associated Genes16
  • Table 2.8: Carcinogens in the Workplace17
  • Table 2.9: Private Funding Levels for the Biotechnology Segment, 1995 to 200718
  • Table 2.10: Global Pharmaceutical Industry R&D Spending, 1995 to 200720
  • Table 2.11: U.S. Government NIH Research Budget, 1995 to 200821
  • Table 2.12: Herceptin Worldwide Sales, 1999 to 200722
  • Table 2.13: Classes of Drugs Used to Treat Breast Cancer22
  • Table 2.14: Women\'s Cancers in the U.S., 200823
  • Table 2.15: Five-Year Relative Survival Rates by Stage at Diagnosis23
  • Table 3.1: Number of Pap Smears Performed by Country29
  • Table 5.1: Pap Tests in Top European Markets52
  • Table 5.2: Pap Tests in Top Asian Markets52
  • Table 6.1: HPV Market Size, 2003 to 201164
  • Table 6.2: Product, Infection and Market65
  • Table 6.3: Instrumentation and Accessories, Infection and Market65
  • Table 7.1: List and Discounted Pricing for Abbott Tumor Marker Tests77
  • Table 10.1: CPT and HCPCS Codes97
  • Table 10.2: National Limitation Amounts98
  • Table 10.3: NLAs for Various CPT Codes100
  • Table 14.1: HPV Types Status and Patents127
  • Table 17.1: Diagnostic Test Kit Products and Markets143

    •  

    Other users found this report page using the following search terms: hpv diagnostics hpv testing reimbursement cytology market cpt diagnostics codes bd markets

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.